At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
OsseoSpeed™ TXdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open, Prospective, Multi-center Study to Evaluate OsseoSpeed™ TX Single Implant 3 mm Diameter in the Anterior Mandible. A 3-years Follow-up Study.
In Brief
A clinical study evaluating OsseoSpeed™ TX for Partially Edentulous Jaw. Completed, enrolled 45 participants across 3 sites.
Detailed Summary
The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 3mm diameter implant in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior mandible up to 3 years after loading. Hypothesis: Early loading of the 3 mm implant is a safe and predictable procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPartially Edentulous Jaw
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
First PostedNov 2011
Primary CompletionSep 2014
Study CompletionOct 2016
TodayJul 2026
First PostedNov 17, 2011
Enrollment StartOct 1, 2011
Primary CompletionSep 1, 2014
Study CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 14.6 years ago
Interventions
OsseoSpeed™ TXdevice
OsseoSpeed™ TX narrow implants (diameter 3 mm) of lengths 11-15 mm